Damian McNamara is a journalist for Medscape Medical News and MDedge. He worked full-time for MDedge as the Miami Bureau covering a dozen medical specialties during 2001-2012, then as a freelancer for Medscape and MDedge, before being hired on staff by Medscape in 2018. Now the two companies are one. He uses what he learned in school – Damian has a BS in chemistry and an MS in science, health and environmental reporting/journalism. He works out of a home office in Miami, with a 100-pound chocolate lab known to snore under his desk during work hours.
News
Initial high-efficacy MS therapy tied to less disability later
- Author:
- Damian McNamara
Starting treatment for relapsing-remitting multiple sclerosis (MS) with high-efficacy therapy (HET) is...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/MontalvoPerero_Mayra_web.jpg)
Predictors of ICH after thrombectomy identified
- Author:
- Damian McNamara
The sum of three variables may predict which patients undergoing thrombectomy up to 24 hours after a stroke are at higher risk of developing...
News
Trials and tribulations: Neurology research during COVID-19
- Author:
- Damian McNamara
Many researchers have redesigned their studies, at least in part to optimize the safety of their participants and research staff.
News
Two rare neurologic conditions linked to COVID-19
- Author:
- Damian McNamara
Two variants of Guillain-Barré syndrome—Miller Fisher syndrome and polyneuritis cranialis—have been linked with COVID-19 infection.
News
COVID-19 linked to large vessel stroke in young adults
- Author:
- Damian McNamara
The virus appears to cause disease through a process of blood clotting, according to an expert.
News
COVID-19: Are acute stroke patients avoiding emergency care?
- Author:
- Damian McNamara
Stroke specialists in New Orleans, Chicago, Seattle, and elsewhere are seeing a precipitous drop in the number of acute strokes at their...
News
Neurologic symptoms and COVID-19: What’s known, what isn’t
- Author:
- Damian McNamara
COVID-19 symptoms may include encephalopathy, ataxia, and other neurologic signs.
News
More evidence backs LDL below 70 to reduce recurrent stroke
- Author:
- Damian McNamara
LOS ANGELES – Targeting LDL below 70 mg/dL for more than 5 years avoided more than one in four subsequent major cardiovascular events among adults...
News
BASILAR: Endovascular treatment improves outcomes in BAO stroke
- Author:
- Damian McNamara
LOS ANGELES – Patients with a posterior basilar artery occlusion who received both endovascular therapy and thrombolysis were almost five times...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/144997_graphic_web.png)
ARCADIA: Predicting risk of atrial cardiopathy poststroke
- Author:
- Damian McNamara
LOS ANGELES – First analysis of risk factors for atrial cardiopathy in patients with an embolic stroke of undetermined source may help to identify...
News
Shingles vaccine linked to lower stroke risk
- Author:
- Damian McNamara
Data from a large Medicare database showed a 20% decrease in stroke risk among adults who received the shingles vaccine.
News
Stroke risk tied to diabetic retinopathy may not be modifiable
- Author:
- Damian McNamara
LOS ANGELES – Findings from a subanalysis of the ACCORD Eye Study showed that glucose, lipid, and hypertension interventions did not mitigate the...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/143796_Lloyd_Jones_Donald_web_0_0.jpg)
Treating LDL to below 70 reduces recurrent stroke
- Author:
- Richard Kirkner
- Damian McNamara
PHILADELPHIA – Results of TST, a rare cholesterol study in patients with a history of ischemic stroke, explore the benefits of treating to a lower...
News
PASI responses with biologics similar among white, nonwhite individuals, study finds
- Author:
- Damian McNamara
MIAMI– Investigators used data from psoriasis studies to determine whether treatment responses differed in skin of color patients.
News
Study highlights need to investigate psoriasis treatment outcomes in skin of color patients
- Author:
- Damian McNamara
MIAMI – Researchers used phase 2 and 3 psoriasis clinical trial data to explore potential differences in treatment response in various ethnic...